Back
Nektar Therapeutics Stock Price Chart
The Next Tech Giant in Your Pocket?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
38
NKTR
Nektar Therapeutics
Last Price:
1.24
Seasonality Move:
7.5%
7 Day Trial
ALL ACCESS PASS
$
7
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.- The current trend is relatively stagnant and NKTR is experiencing selling pressure, which indicates risk of future bearish movement.
Nektar Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.27 | Sell |
| 20-day SMA: | 1.25 | Buy |
| 50-day SMA: | 1.28 | Sell |
| 200-day SMA: | 1.07 | Buy |
| 8-day EMA: | 1.26 | Sell |
| 20-day EMA: | 1.25 | Buy |
| 50-day EMA: | 1.26 | Sell |
| 200-day EMA: | 1.19 | Buy |
Nektar Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Buy |
| Relative Strength Index (14 RSI): | 50.72 | Buy |
| Chaikin Money Flow: | -320857 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.19 - 1.31) | Buy |
| Bollinger Bands (100): | (1.16 - 1.54) | Sell |
Nektar Therapeutics Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Nektar Therapeutics Stock
Is Nektar Therapeutics Stock a Buy?
- Nektar Therapeutics share price is 1.26 while NKTR 8-day simple moving average is 1.27, which is a Sell signal.
- The stock price of NKTR is 1.26 while Nektar Therapeutics 20-day SMA is 1.25, which makes it a Buy.
- Nektar Therapeutics 50-day simple moving average is 1.28 while NKTR share price is 1.26, making it a Sell technically.
- NKTR stock price is 1.26 and Nektar Therapeutics 200-day simple moving average is 1.07, creating a Buy signal.
NKTR Technical Analysis vs Fundamental Analysis
Sell
38
Nektar Therapeutics (NKTR)
is a Sell
Is Nektar Therapeutics a Buy or a Sell?
-
Nektar Therapeutics stock is rated a Sell
The current Nektar Therapeutics [NKTR] share price is $1.26. The Score for NKTR is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
Nektar Therapeutics Stock Info
Market Cap:
231.94M
Price in USD:
1.26
Share Volume:
427.81K
Nektar Therapeutics 52-Week Range
52-Week High:
1.93
52-Week Low:
0.41
Sell
38
Nektar Therapeutics (NKTR)
is a Sell
Nektar Therapeutics Share Price Forecast
-
What is the Nektar Therapeutics stock price today?
The Nektar Therapeutics stock price is 1.26 USD today. -
Will NKTR stock go up or go down?
Nektar Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Nektar Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Nektar Therapeutics is overvalued.
Is Nektar Therapeutics Stock a Buy?
- Nektar Therapeutics share price is 1.26 while NKTR 8-day exponential moving average is 1.26, which is a Sell signal.
- The stock price of NKTR is 1.26 while Nektar Therapeutics 20-day EMA is 1.25, which makes it a Buy.
- Nektar Therapeutics 50-day exponential moving average is 1.26 while NKTR share price is 1.26, making it a Sell technically.
- NKTR stock price is 1.26 and Nektar Therapeutics 200-day simple moving average is 1.19, creating a Buy signal.
Fundamental Analysis of Nektar Therapeutics
Is Nektar Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.61 per share, and a decrease next year of $0.06 per share.
Technical Analysis of Nektar Therapeutics
Should I short Nektar Therapeutics stock?
- NKTR Moving Average Covergence Divergence (MACD) indicator is 0, suggesting Nektar Therapeutics is a Buy
- Nektar Therapeutics Relative Strength Index (RSI) is 50.72, which suggest Nektar Therapeutics is overbought
- The Bollinger Bands (25) for Nektar Therapeutics is (1.19 - 1.31), which suggest Nektar Therapeutics is a Sell
- The Bollinger Bands (100) for Nektar Therapeutics is (1.16 - 1.54), which suggest Nektar Therapeutics is a Sell
* Nektar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.